Navigation Links
Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
Date:2/15/2012

PITTSBURGH, Feb. 15, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it plans to change the name of its fully integrated branded specialty pharmaceutical business from Dey Pharma to Mylan Specialty.

Mylan CEO Heather Bresch said: "In 2007, we united legacy Mylan, Matrix Laboratories and the generics business of Merck KGaA, which included the acquisition of our specialty subsidiary Dey Pharma, and transformed Mylan into the diversified, global business we are today. Over the past four years, Dey's strong performance has played an important role in our successful transformation and continues to be a valuable growth driver for Mylan."

Bresch continued: "The name change to Mylan Specialty is an important milestone and a natural step in our company's evolution.  Bringing Dey under the Mylan brand will align our specialty business even more directly with everything Mylan stands for – innovating to satisfy unmet needs, making reliability and service a habit, doing what's right, not what's easy, and impacting the future through passionate leadership. Further, operating under one brand will allow us to speak with a more unified and powerful voice as we pursue our mission of providing the world's 7 billion people access to high quality medicine."

Mylan Specialty President John Thievon said: "The decision to change our name from Dey to Mylan Specialty underscores Mylan's deep commitment to this business. Further, the name change provides us with the opportunity to fully maximize the power of the Mylan brand, its reputation for quality and service, and its strong relationship with customers around the world."

Dey is conducting business as Mylan Specialty effective immediately; however, Dey Pharma, L.P. will continue to be used as the legal entity until all required transition steps are completed.

Mylan Specialty has corporate offices in Basking Ridge, N.J. The company also has operations in Allen, Texas and Napa, Calif. Mylan Specialty has approximately 725 employees who work collaboratively on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, severe allergic reactions and psychiatric disorders.

About Mylan

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Actively Addressing Shortage of Preservative-Free Methotrexate Injection
2. Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers
3. Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant
4. Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
5. Mylan Receives Tentative FDA Approval for Generic Version of Lipitor®
6. Mylan to Host Investor Day on Feb. 21, 2012, in New York City
7. Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam
8. Mylan Launches First Generic Version of Teveten® Tablets
9. Mylan Receives Approval for First-to-File Generic Keppra XR® Extended-Release Tablets
10. Mylan Receives WHO Approval for Innovative Second-Line-in-a-Box HIV/AIDS Treatment
11. Mylan Launches Generic Version of Toprol-XL® Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... NASHVILLE, Tenn. , May 26, 2016 ... provider of software and analytics, network solutions ... healthcare, today announced it entered into a ... leading provider of outpatient software solutions and ... surgery centers, specialty hospitals and rehabilitation clinics ...
(Date:5/25/2016)... Germany and GERMANTOWN, Maryland ... (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) today ... co-development agreement with Therawis Diagnostics GmbH to develop and commercialize ... develop and market PITX2 as a marker to predict effectiveness ... cancer patients. "We are pleased to partner with ...
(Date:5/25/2016)... Va. , May 25, 2016  Granger Diagnostics ... sequencing test for wounds and infections. This test ... parasites, and select viruses. The test requires only ... David G. Bostwick , ... testing to facilitate wound healing: "We are excited ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in ... courtesy of leaders in the nursing and health care industry. It also provides ... and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is adding ...
(Date:5/26/2016)... ... 2016 , ... Despite last week’s media reports hinting at a June rate ... until March 2017 for an interest rate increase, according to Rajeev Dhawan of the ... “The Federal Open Market Committee (FOMC) dot charts are of interest to the press ...
(Date:5/26/2016)... St. Louis, Missouri (PRWEB) , ... May 26, ... ... optimal cost, quality and clinical outcomes, hosted members and suppliers for its inaugural ... with a focus on their mission of elevating the operational health of America’s ...
(Date:5/26/2016)... ... May 26, 2016 , ... The Woodlands at ... offering a new model of care for living and healing, celebrated its grand opening, ... Life in a Real Home provided by Empowered Staff. , “This is an incredibly ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... solutions for drugs, biologics, consumer health and global clinical supply services, today announced ... to support the company’s continued investment and strategic growth plans in the Asia ...
Breaking Medicine News(10 mins):